Please login to the form below

Not currently logged in
Email:
Password:

Chlamydia test approved for use in EU

A new test for chlamydia, produced by pharmaceutical company Roche, has received CE Mark certification, allowing it to be sold in the EU for clinical use
A new test for chlamydia, produced by pharmaceutical company Roche, has received CE Mark certification, allowing it to be sold in the EU for clinical use.

Chlamydia trachomatis is the most commonly diagnosed STI in England, with approximately two-thirds of cases affecting younger age groups. The infection often has no obvious symptoms and left undetected it will not only continue to be spread through the community, but can also lead to complications such as pelvic inflammatory disease or infertility in women.

"Unexpected mutations in the DNA of an infectious agent such as chlamydia can disrupt laboratory testing and, by extension, proper treatment of patients," said Dr Teresa L. Wright, OBE, chief medical officer at Roche Molecular Diagnostics.

This test, known as COBAS TaqMan CT Test v2.0, differs from other tests as it uses a dual target approach helping to ensure reliability even when mutations occur within the bacteria's DNA.

Using specifically designed analysis equipment, results can be obtained just two and a half hours after a sample is prepared.

13th June 2008

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
OPEN Access Consulting

OPEN Access Consulting is a specialist market access agency within the OPEN Health Group. As value communications experts we specialise...

Latest intelligence

50 questions for delivering an exceptional healthcare brand experience
Our 50-question brand planning checklist for healthcare ensures you deliver an exceptional experience, based on what your stakeholders want and need...
The brand strategy revolution
Introducing a new tool for developing a stakeholder-centric brand, based on the experience your patients and their HCPs want and need....
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....

Infographics